NLS
October 8, 2013
Today, at 12:45 a.m. CET the earliest, the Nobel Prize in Physics 2013 will be announced. Watch the announcement live here:
Updated: December 3, 2025, 09:47 am
Published: October 8, 2013
Top stories
Business article – July 24, 2026
The Novo Nordisk Foundation is funding a new pan-European initiative to accelerate drug discovery and the development of next generation therapeutics for cardiometabolic diseases (CMDs).
In a new job – July 24, 2026
The Board of Directors and the CEO assess that having a consolidated management team on site in Uppsala, close to the core operations, will provide the best conditions for continuing to build the organization required for the next phase and for advancing development programs, the company states.
Europe – July 23, 2026
With an intended investment volume of more than EUR 200 million over the next 5 years, Fresenius Ventures targets growth fields adjacent to Fresenius’ existing strategic platforms (Bio)Pharma, MedTech, and Care Provision.
Acquisition – July 20, 2026
The offer values PolyPeptide’s equity at approximately CHF 1.46 billion.
Related posts
Business article - June 29, 2026
The newly formed European Life Sciences Coalition (ELSC) has sent an open letter to leading decision-makers and politicians in the EU and Sweden, urging them to take action.
Biotech Business - June 29, 2026
The board of directors of Cantargia has announced the outcome of the rights issue of shares that was announced on 28 May 2026.
Uncategorized - April 29, 2026
The US‑based company has debuted in combined seed and Series A financing to advance a portfolio of mid‑stage neurology and neuropsychiatry drugs in‑licensed from Eisai and Hansoh.
Biotech Business - December 9, 2025
BioArctic’s partner Eisai has announced that Leqembi (lecanemab), has been included in the “Commercial Insurance Innovative Drug List”, recently introduced by the National Healthcare Security Administration (NHSA) of China.
Collaboration - July 30, 2025
Earlier this summer, the European Commission launched a new strategy to make Europe the most attractive place in the world for life sciences by 2030.
Biotech Business - December 9, 2024
MetaCurUm has been awarded SEK 1 million from the Swedish Innovation Agency, Vinnova, under the "Acceleration of Deeptech Companies 2024" initiative.
Uncategorized - December 1, 2024
Mentice has appointed Frans Venker as its new Chief Executive Officer, effective January 1, 2025.
This site uses cookies
Read more about our privacy policy
The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.
The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.
The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.